Want to join the conversation?
$GILD said the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, adopted a positive opinion on its Marketing Authorization Application for two doses of Descovy, an investigational fixed-dose combination for the treatment of HIV-1 infection in combination with other HIV antiretroviral agents.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.